PharVision Advisers’s Repay Holdings RPAY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$38.5K Buy
+14,814
New +$47.4K 0.39% 97
2025
Q4
Sell
-27,759
Closed -$145K 963
2025
Q3
$145K Buy
+27,759
New +$149K 0.08% 576
2025
Q1
Sell
-14,975
Closed -$114K 479
2024
Q4
$114K Buy
+14,975
New +$120K 0.1% 366

Other funds holding RPAY

PharVision Advisers's RPAY Position: Q1 2026 in Review

PharVision Advisers opened a new position in Repay Holdings (RPAY) in Q1 2026: 14,814 shares worth $38.5K. The stake represents 0.39% of the portfolio and ranks #97 among its holdings. This is a return to the name: PharVision Advisers previously reported a position in RPAY as recently as Q3 2025.

PharVision Advisers first reported a position in RPAY in Q4 2024 and has held it in 3 quarters since. The position peaked at $145K in Q3 2025. 145 funds tracked by Wall St. Rank hold RPAY as of Q1 2026.

  • PharVision Advisers held 14,814 shares of Repay Holdings worth $38.5K as of Q1 2026.
  • Repay Holdings was a new PharVision Advisers position in Q1 2026.
  • Repay Holdings made up 0.39% of PharVision Advisers's portfolio in Q1 2026, its #97 holding.
  • PharVision Advisers first reported a position in Repay Holdings in Q4 2024 and has held it in 3 quarters since.
  • PharVision Advisers's Repay Holdings position peaked at $145K in Q3 2025.
  • 145 funds tracked by Wall St. Rank held Repay Holdings as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.